Home / Recalls / Actavis Laboratories, FL, Inc. / D-0118-2017

D-0118-2017 Class III Ongoing

Recalled by Actavis Laboratories, FL, Inc. — Davie, FL

Recall Details

Product Type
Drugs
Report Date
November 9, 2016
Initiation Date
August 30, 2016
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
15,984 bottles

Product Description

Ramipril Capsules, USP, 1.25 mg, 30-count bottle, Rx only, Manufactured by: Arrow Pharm (Malta) Ltd., Birzebbugia, BBG3000, Malta; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 16252-570-30.

Reason for Recall

Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.

Distribution Pattern

Nationwide and Puerto Rico

Code Information

Lot #: 1136091A, Incorrectly Labeled Exp: 03/18

Other recalls by Actavis Laboratories, FL, Inc.

  • D-0014-2016 Class II — Metformin Hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, Rx o (September 25, 2015)
  • D-1285-2015 Class III — Desmopressin Acetate Tablets, 0.1mg, 100 Count Bottles, Rx Only. Manufactured by (June 23, 2015)
  • D-0488-2015 Class III — Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 (March 26, 2015)
  • D-0258-2015 Class II — Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-coun (September 26, 2014)
  • D-1616-2014 Class II — Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-coun (April 24, 2014)
  • D-1617-2014 Class II — Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 50 mg/0.2 mg, 60-coun (April 24, 2014)